These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 37451379)

  • 21. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
    Yamagishi SI; Sotokawauchi A; Matsui T
    Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
    Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Maillard reaction. Pathogenic effects].
    Voyer LE; Alvarado C
    Medicina (B Aires); 2019; 79(2):137-143. PubMed ID: 31048279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of advanced glycation end-products in hypertension in diabetic patients: a systematic review.
    Fuhr JC; Ramos MEK; Piovesan F; Renner LO; Siqueira LO
    J Bras Nefrol; 2022; 44(4):557-572. PubMed ID: 36300672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products.
    Li L; Song Q; Zhang X; Yan Y; Wang X
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
    Yamagishi S; Taguchi K; Fukami K
    Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina.
    Oshitari T
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.
    Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2007; 13(27):2832-6. PubMed ID: 17897026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breath of fresh air: Investigating the link between AGEs, sRAGE, and lung diseases.
    Delrue C; Speeckaert R; Delanghe JR; Speeckaert MM
    Vitam Horm; 2024; 125():311-365. PubMed ID: 38997169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments.
    Wasim R; Mahmood T; Siddiqui MH; Ahsan F; Shamim A; Singh A; Shariq M; Parveen S
    Life Sci; 2022 Oct; 307():120860. PubMed ID: 35940220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Dietary Polyphenols Prevent the Formation of Toxic Compounds from Maillard Reaction?
    Del Turco S; Basta G
    Curr Drug Metab; 2016; 17(6):598-607. PubMed ID: 26953241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maillard reaction in food allergy: Pros and cons.
    Gupta RK; Gupta K; Sharma A; Das M; Ansari IA; Dwivedi PD
    Crit Rev Food Sci Nutr; 2018 Jan; 58(2):208-226. PubMed ID: 26980434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
    Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
    Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.
    Deluyker D; Evens L; Bito V
    Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
    Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
    Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor Mediated Effects of Advanced Glycation End Products (AGEs) on Innate and Adaptative Immunity: Relevance for Food Allergy.
    Briceno Noriega D; Zenker HE; Croes CA; Ewaz A; Ruinemans-Koerts J; Savelkoul HFJ; van Neerven RJJ; Teodorowicz M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Food Processing: The Influence of the Maillard Reaction on Immunogenicity and Allergenicity of Food Proteins.
    Teodorowicz M; van Neerven J; Savelkoul H
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28777346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic transit of dietary advanced glycation end-products - the case of N
    Tessier FJ; Boulanger E; Howsam M
    Glycoconj J; 2021 Jun; 38(3):311-317. PubMed ID: 32990827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.